-
1
-
-
0025921178
-
Classification and diagnosis of mastocytosis: Current status
-
Metcalfe DD: Classification and diagnosis of mastocytosis: Current status. J Invest Dermatol 1991;96(suppl):25-45.
-
(1991)
J Invest Dermatol
, vol.96
, Issue.SUPPL.
, pp. 25-45
-
-
Metcalfe, D.D.1
-
2
-
-
0026073372
-
Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells
-
Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991;146: 1410-1415.
-
(1991)
J Immunol
, vol.146
, pp. 1410-1415
-
-
Kirshenbaum, A.S.1
Kessler, S.W.2
Goff, J.P.3
Metcalfe, D.D.4
-
3
-
-
0344778472
-
Two types of human mast cells that have distinct neutral protease compositions
-
Irani AA, Schlechter NM, Craig SS, DeBlois G, Schwartz LB: Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83: 4464-4468.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 4464-4468
-
-
Irani, A.A.1
Schlechter, N.M.2
Craig, S.S.3
Deblois, G.4
Schwartz, L.B.5
-
5
-
-
0025242472
-
Mast cells as a source of multifunctional cytokines
-
Gordon JR, Burd PR, Galli SJ: Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-464.
-
(1990)
Immunol Today
, vol.11
, pp. 458-464
-
-
Gordon, J.R.1
Burd, P.R.2
Galli, S.J.3
-
6
-
-
0025332846
-
Mast cells as a source of both performed and immunologically inducible TNF-α/cachectin
-
Gordon JR, Galli SJ: Mast cells as a source of both performed and immunologically inducible TNF-α/cachectin. Nature 1990;346: 274-276.
-
(1990)
Nature
, vol.346
, pp. 274-276
-
-
Gordon, J.R.1
Galli, S.J.2
-
7
-
-
0027180002
-
Human mast cells produce IL-8
-
Möller A, Lippert V, Lessmann D, Kolde G, Welker P, Schadendorf D, Rosenbach T, Luger T, Czarnetzki BM: Human mast cells produce IL-8. J Immunol 1993;151:3261-3266.
-
(1993)
J Immunol
, vol.151
, pp. 3261-3266
-
-
Möller, A.1
Lippert, V.2
Lessmann, D.3
Kolde, G.4
Welker, P.5
Schadendorf, D.6
Rosenbach, T.7
Luger, T.8
Czarnetzki, B.M.9
-
8
-
-
0021268981
-
Cutaneous mastocytosis without clinically obvious skin lesions
-
Kendall ME, Fields JR, King LE Jr: Cutaneous mastocytosis without clinically obvious skin lesions. J Am Acad Dermatol 1984;10: 903-905.
-
(1984)
J am Acad Dermatol
, vol.10
, pp. 903-905
-
-
Kendall, M.E.1
Fields, J.R.2
King Jr., L.E.3
-
9
-
-
0025922016
-
Conclusion: Clinical advances in mastocytosis: An interdisciplinary round table discussion
-
Metcalfe DD: Conclusion: Clinical advances in mastocytosis: An interdisciplinary round table discussion. J Invest Dermatol 1991;96 (suppl):64-65.
-
(1991)
J Invest Dermatol
, vol.96
, Issue.SUPPL.
, pp. 64-65
-
-
Metcalfe, D.D.1
-
10
-
-
0024271215
-
Systemic mast cell disease: Analysis of 58 cases and review of the literature
-
Travis WD, Li CY, Bergstrahl EJ, Yam LT, Swee RG: Systemic mast cell disease: Analysis of 58 cases and review of the literature. Medicine 1988;67:345-368.
-
(1988)
Medicine
, vol.67
, pp. 345-368
-
-
Travis, W.D.1
Li, C.Y.2
Bergstrahl, E.J.3
Yam, L.T.4
Swee, R.G.5
-
11
-
-
0027310969
-
Altered metabolism of mast cell growth factor in cutaneous mastocytosis
-
Longely BJ Jr, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, Halaban R: Altered metabolism of mast cell growth factor in cutaneous mastocytosis. N Engl J Med 1993; 328:1302-1307.
-
(1993)
N Engl J Med
, vol.328
, pp. 1302-1307
-
-
Longely Jr., B.J.1
Morganroth, G.S.2
Tyrrell, L.3
Ding, T.G.4
Anderson, D.M.5
Williams, D.E.6
Halaban, R.7
-
12
-
-
2742529418
-
Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand
-
Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-3351.
-
(1987)
EMBO J
, vol.6
, pp. 3341-3351
-
-
Yarden, Y.1
Kuang, W.J.2
Yang-Feng, T.3
Coussens, L.4
Munemitsu, S.5
Dull, T.J.6
Chen, E.7
Schlessinger, J.8
Francke, U.9
Ullrich, A.10
-
13
-
-
0028856070
-
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
-
Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci 1995; 92:10560-10564.
-
(1995)
Proc Natl Acad Sci
, vol.92
, pp. 10560-10564
-
-
Nagata, H.1
Worobec, A.S.2
Oh, C.K.3
Chowdhury, B.A.4
Tannenbaum, S.5
Suzuki, Y.6
Metcalfe, D.D.7
-
14
-
-
0009013631
-
Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
-
Longley BJ, Tyrrell L. Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I: Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-314.
-
(1996)
Nat Genet
, vol.12
, pp. 312-314
-
-
Longley, B.J.1
Tyrrell, L.2
Lu, S.Z.3
Ma, Y.S.4
Langley, K.5
Ding, T.G.6
Duffy, T.7
Jacobs, P.8
Tang, L.H.9
Modlin, I.10
-
15
-
-
0027359443
-
Identification of mutation in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product
-
Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, Matsuzawa Y, Kitamura Y, Kanakura Y: Identification of mutation in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92:1736-1744.
-
(1993)
J Clin Invest
, vol.92
, pp. 1736-1744
-
-
Furitsu, T.1
Tsujimura, T.2
Tono, T.3
Ikeda, H.4
Kitayama, H.5
Koshimizu, U.6
Sugahara, H.7
Butterfield, J.H.8
Ashman, L.K.9
Kanayama, Y.10
Matsuzawa, Y.11
Kitamura, Y.12
Kanakura, Y.13
-
16
-
-
0030998028
-
Chronically KIT-stimulated clonally derived human mast cells show heterogeneity in different tissue microenvironments
-
Longley BJ, Tyrell L, Lu S, Ma Y, Klump V, Murphy GF: Chronically KIT-stimulated clonally derived human mast cells show heterogeneity in different tissue microenvironments. J Invest Dermatol 1997;108:792-796.
-
(1997)
J Invest Dermatol
, vol.108
, pp. 792-796
-
-
Longley, B.J.1
Tyrell, L.2
Lu, S.3
Ma, Y.4
Klump, V.5
Murphy, G.F.6
-
17
-
-
0025978296
-
Urticaria pigmentosa: Systemic evaluation and successful treatment with topical steroids
-
Guzzo S, Larker R, Roberts J II, Fox K, Schlechter N, Lazarus GS: Urticaria pigmentosa: Systemic evaluation and successful treatment with topical steroids. Arch Dermatol 1991;127:191-196.
-
(1991)
Arch Dermatol
, vol.127
, pp. 191-196
-
-
Guzzo, S.1
Larker, R.2
Roberts Jr., J.3
Fox, K.4
Schlechter, N.5
Lazarus, G.S.6
-
18
-
-
84943436616
-
The bone marrow in urticaria pigmentosa and systemic mastocytosis
-
Ridell B, Olafsson JH, Roupe G, Swolin B, Granerus G, Rödjer S, Enerbäck L: The bone marrow in urticaria pigmentosa and systemic mastocytosis. Arch Dermatol 1986;122: 422-427.
-
(1986)
Arch Dermatol
, vol.122
, pp. 422-427
-
-
Ridell, B.1
Olafsson, J.H.2
Roupe, G.3
Swolin, B.4
Granerus, G.5
Rödjer, S.6
Enerbäck, L.7
-
19
-
-
0023764931
-
Gastrointestinal dysfunction in systemic mastocytosis: A prospective study
-
Cherner JA, Jensen RT, Dubois A, O'Dorisio TM, Gardner JD, Metcalfe DD: Gastrointestinal dysfunction in systemic mastocytosis: A prospective study. Gastroenterology 1988;95: 657-667.
-
(1988)
Gastroenterology
, vol.95
, pp. 657-667
-
-
Cherner, J.A.1
Jensen, R.T.2
Dubois, A.3
O'Dorisio, T.M.4
Gardner, J.D.5
Metcalfe, D.D.6
-
20
-
-
0023907495
-
Carcinoid syndrome and disorders of mast cell activation including systemic mastocytosis
-
Roberts LJ II: Carcinoid syndrome and disorders of mast cell activation including systemic mastocytosis. Endocrinol Metab Clin North Am 1988;17:415-436.
-
(1988)
Endocrinol Metab Clin North am
, vol.17
, pp. 415-436
-
-
Roberts Jr., L.J.1
-
21
-
-
0023695019
-
Significance of associated mast cell disease with associated hematologic disorders
-
Travis WD, Li CY, Yam LT, Bergstralh EJ, Swee RG: Significance of associated mast cell disease with associated hematologic disorders. Cancer 1988;62:965-972.
-
(1988)
Cancer
, vol.62
, pp. 965-972
-
-
Travis, W.D.1
Li, C.Y.2
Yam, L.T.3
Bergstralh, E.J.4
Swee, R.G.5
-
24
-
-
0029067610
-
Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2
-
Morrow JD, Guzzo C, Lazerus G, Oates JA, Jackson Roberts L II: Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2. J Invest Dermatol 1995;104:937-940.
-
(1995)
J Invest Dermatol
, vol.104
, pp. 937-940
-
-
Morrow, J.D.1
Guzzo, C.2
Lazerus, G.3
Oates, J.A.4
Jackson Roberts II, L.5
-
25
-
-
0025921183
-
The treatment of mastocytosis: An overview
-
Metcalfe DD: The treatment of mastocytosis: An overview. J Invest Dermatol 1991;96(suppl): 55-56.
-
(1991)
J Invest Dermatol
, vol.96
, Issue.SUPPL.
, pp. 55-56
-
-
Metcalfe, D.D.1
-
26
-
-
0018687287
-
Oral disodium cromoglycate in the treatment of systemic mastocytosis
-
Soter NA, Austen KF, Wassermann SI: Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979;301: 465-469.
-
(1979)
N Engl J Med
, vol.301
, pp. 465-469
-
-
Soter, N.A.1
Austen, K.F.2
Wassermann, S.I.3
-
27
-
-
0021907622
-
Comparison of the therapeutic efficiency of cromolyn disodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis
-
Frieri M, Ailing DW, Metcalfe DD: Comparison of the therapeutic efficiency of cromolyn disodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Am J Med 1985;78:9-14.
-
(1985)
Am J Med
, vol.78
, pp. 9-14
-
-
Frieri, M.1
Ailing, D.W.2
Metcalfe, D.D.3
-
28
-
-
0021237539
-
Response of cutaneous mast cell to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural and biochemical investigations
-
Kolde G, Frosch PJ, Czarnetzki BM: Response of cutaneous mast cell to PUVA in patients with urticaria pigmentosa: Histomorphometric, ultrastructural and biochemical investigations. J Invest Dermatol 1984;83:75-78.
-
(1984)
J Invest Dermatol
, vol.83
, pp. 75-78
-
-
Kolde, G.1
Frosch, P.J.2
Czarnetzki, B.M.3
-
30
-
-
0020660043
-
A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa
-
Czarnetzki BM: A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica 1983;166:44-47.
-
(1983)
Dermatologica
, vol.166
, pp. 44-47
-
-
Czarnetzki, B.M.1
-
31
-
-
0026570013
-
Response to interferon alfa-2b in a patient with systemic mastocytosis
-
Kluin-Nelemans HC, Jansen JH, Breukelman H, Wolthers BG, Kluin PM, Kroon HM, Willemze R: Response to interferon alfa-2b in a patient with systemic mastocytosis. N Engl J Med 1992;326:619-623.
-
(1992)
N Engl J Med
, vol.326
, pp. 619-623
-
-
Kluin-Nelemans, H.C.1
Jansen, J.H.2
Breukelman, H.3
Wolthers, B.G.4
Kluin, P.M.5
Kroon, H.M.6
Willemze, R.7
-
32
-
-
0029013848
-
Treatment of urticaria pigmentosa using interferon alpha
-
Kolde G, Sunderkötter C, Luger T: Treatment of urticaria pigmentosa using interferon alpha. Br J Dermatol 1995;133:91-94.
-
(1995)
Br J Dermatol
, vol.133
, pp. 91-94
-
-
Kolde, G.1
Sunderkötter, C.2
Luger, T.3
-
33
-
-
0029097623
-
Treatment of systemic mastocytosis with interferon-γ: Failure after appearance of anti-IFN-γ antibodies
-
Fiehn C, Prümmer O, Gallati H, Heilig B, Hunstein W: Treatment of systemic mastocytosis with interferon-γ: Failure after appearance of anti-IFN-γ antibodies. Eur J Clin Invest 1995; 25:615-618.
-
(1995)
Eur J Clin Invest
, vol.25
, pp. 615-618
-
-
Fiehn, C.1
Prümmer, O.2
Gallati, H.3
Heilig, B.4
Hunstein, W.5
-
34
-
-
0028912332
-
Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon alfa therapy
-
Petit A, Pulik M, Gaulier A, Lionnet F, Mahe A, Sigal M: Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon alfa therapy. J Am Acad Dermatol 1995;32: 850-853.
-
(1995)
J am Acad Dermatol
, vol.32
, pp. 850-853
-
-
Petit, A.1
Pulik, M.2
Gaulier, A.3
Lionnet, F.4
Mahe, A.5
Sigal, M.6
-
36
-
-
0028226956
-
Interferon treatment of patients with chronic urticaria and mastocytosis
-
Czarnetzki BM, Algermissen B, Jeep S, Haas N, Nürnberg W, Müller K, Kropp JD: Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 1994;30:500-501.
-
(1994)
J am Acad Dermatol
, vol.30
, pp. 500-501
-
-
Czarnetzki, B.M.1
Algermissen, B.2
Jeep, S.3
Haas, N.4
Nürnberg, W.5
Müller, K.6
Kropp, J.D.7
-
37
-
-
0025780558
-
Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon
-
Pardini S, Bosincu L, Bonfigli S, Dore F, Longinotti M: Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon. Acta Haematol 1991;85:220.
-
(1991)
Acta Haematol
, vol.85
, pp. 220
-
-
Pardini, S.1
Bosincu, L.2
Bonfigli, S.3
Dore, F.4
Longinotti, M.5
|